Literature DB >> 5302923

A serological survey for cholera antibodies in rural east Pakistan. 2. A comparison of antibody titres in the innunized and control populationd of a cholera-vaccine field-trial area and the relation of antibody titre to cholera case rate.

W H Mosley, A S Benenson, R Barui.   

Abstract

Controlled field trials of a highly antigenic cholera vaccine were held in Matlab Bazar in rural East Pakistan in 1963 and again in 1964. In July-September 1965, a serological survey for cholera antibodies was carried out on a random sample of the field-trial population. This survey revealed that it was possible to demonstrate the effect of a single injection of the cholera vaccine per head on the proportion of the population with detectable vibriocidal and agglutinating antibody 10 and 22 months after injection. More significantly, the reduction in cholera case rate caused by the vaccine could be correlated with the rise in vibriocidal antibody after vaccination, suggesting that the serological response to vaccine in man may be a useful measure of vaccine potency. The survey also indicated that in this endemic cholera area, with a high level of immunity in adults, a single injection of cholera vaccine was in fact a booster dose for the majority of the population. Thus, the results of cholera vaccine field trials in endemic areas cannot be directly extrapolated to predict the effects of the same vaccine in non-endemic areas.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5302923      PMCID: PMC2554488     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  6 in total

1.  FIELD TRIAL OF CHOLERA VACCINE IN RURAL EAST PAKISTAN. FIRST YEAR OF OBSERVATION.

Authors:  R O OSEASOHN; A S BENENSON; M FAHIMUDDIN
Journal:  Lancet       Date:  1965-02-27       Impact factor: 79.321

2.  Cholera vaccine field trials in east Pakistan. 1. Reaction and antigenicity studies.

Authors:  A S Benenson; P R Joseph; R O Oseasohn
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

3.  A serological survey for cholear antibodies in rural east Pakistan. 1. The distribution of antibody in the control population of a cholera-vaccine field-trial area and the relation of antibody titre to the pattern of endemic cholera.

Authors:  W H Mosley; A S Benenson; R Barui
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

4.  Cholera vaccine field trials in east Pakistan. 2. Effectiveness in the field.

Authors:  A S Benenson; W H Mosley; M Fahimuddin; R O Oseasohn
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

5.  Serological studies in cholera. 2. The vibriocidal antibody response of cholera patients determined by a microtechnique.

Authors:  A S Benenson; A Saad; W H Mosley
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

6.  Serological studies in cholera. I. Vibrio agglutinin response of cholera patients determined by a microtechnique.

Authors:  A S Benenson; A Saad; M Paul
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

  6 in total
  27 in total

1.  Immunochemical characterization of synthetic hexa-, octa- and decasaccharide conjugate vaccines for Vibrio cholerae O:1 serotype Ogawa with emphasis on antigenic density and chain length.

Authors:  Peter Ftacek; Victor Nelson; Shousun C Szu
Journal:  Glycoconj J       Date:  2013-08-17       Impact factor: 2.916

2.  Safety and immunogenicity of single-dose live oral cholera vaccine strain CVD 103-HgR, prepared from new master and working cell banks.

Authors:  Wilbur H Chen; Richard N Greenberg; Marcela F Pasetti; Sofie Livio; Michael Lock; Marc Gurwith; Myron M Levine
Journal:  Clin Vaccine Immunol       Date:  2013-10-30

3.  Transcutaneous immunization with a synthetic hexasaccharide-protein conjugate induces anti-Vibrio cholerae lipopolysaccharide responses in mice.

Authors:  Julianne E Rollenhagen; Anuj Kalsy; Rina Saksena; Alaullah Sheikh; Mohammad Murshid Alam; Firdausi Qadri; Stephen B Calderwood; Pavol Kovác; Edward T Ryan
Journal:  Vaccine       Date:  2009-06-27       Impact factor: 3.641

4.  Suppression of growth of Vibrio cholerae in the intestine of immunized mice.

Authors:  J Knop; J E Bellamy
Journal:  Med Microbiol Immunol       Date:  1976-06-01       Impact factor: 3.402

5.  A controlled field trial of plain and aluminium hydroxide-adsorbed cholera vaccines in Surabaya, Indonesia, during 1973--75.

Authors:  J S Saroso; W Bahrawi; H Witjaksono; R L Budiarso; Z Bencić; W E Dewitt; C Z Gomez
Journal:  Bull World Health Organ       Date:  1978       Impact factor: 9.408

6.  A serological survey for cholear antibodies in rural east Pakistan. 1. The distribution of antibody in the control population of a cholera-vaccine field-trial area and the relation of antibody titre to the pattern of endemic cholera.

Authors:  W H Mosley; A S Benenson; R Barui
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

7.  Model distinguishability and inference robustness in mechanisms of cholera transmission and loss of immunity.

Authors:  Elizabeth C Lee; Michael R Kelly; Brad M Ochocki; Segun M Akinwumi; Karen E S Hamre; Joseph H Tien; Marisa C Eisenberg
Journal:  J Theor Biol       Date:  2017-01-24       Impact factor: 2.691

8.  Improved protection against cholera in adult rabbits with a combined flagellar-toxoid vaccine.

Authors:  I G Resnick; C W Ford; G M Shackleford; L J Berry
Journal:  Infect Immun       Date:  1980-11       Impact factor: 3.441

9.  Memory T-cell responses to Vibrio cholerae O1 infection.

Authors:  Ana A Weil; Mohammad Arifuzzaman; Taufiqur R Bhuiyan; Regina C LaRocque; Aaron M Harris; Emily A Kendall; Azim Hossain; Abdullah A Tarique; Alaullah Sheikh; Fahima Chowdhury; Ashraful I Khan; Farhan Murshed; Kenneth C Parker; Kalyan K Banerjee; Edward T Ryan; Jason B Harris; Firdausi Qadri; Stephen B Calderwood
Journal:  Infect Immun       Date:  2009-08-24       Impact factor: 3.441

10.  Production and sequence validation of a complete full length ORF collection for the pathogenic bacterium Vibrio cholerae.

Authors:  Andreas Rolfs; Wagner R Montor; Sang Sun Yoon; Yanhui Hu; Bhupinder Bhullar; Fontina Kelley; Seamus McCarron; Daniel A Jepson; Binghua Shen; Elena Taycher; Stephanie E Mohr; Dongmei Zuo; Janice Williamson; John Mekalanos; Joshua Labaer
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.